Based on this, we wanted to determine whether ATR germline mutations are involved in susceptibility to breast and/or ovarian cancer, and conducted a mutation analysis of all 47 coding exons and exon–intron boundaries in the affected index cases in 126 families. The gene discussed is ATR; the disease is ovarian cancer.